AMY M RILEY
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner JOHNSTOWN, PA NPI 1528009552
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner PA PFIZER INC. All categories
General Payments — all program years on this page
$8,118.73
- Category: General Payments
- Program years: PY2021–2024
- Record count: 325
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,882.91 across 62 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,248.28 | 54 |
| Education | $634.63 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $371.59 | 9 |
| Daiichi Sankyo Inc. | $295.62 | 7 |
| E.R. Squibb & Sons, L.L.C. | $214.75 | 7 |
| ABBVIE INC. | $194.50 | 3 |
| Janssen Biotech, Inc. | $91.76 | 3 |
| BeiGene USA, Inc. | $75.24 | 3 |
| Lilly USA, LLC | $72.98 | 3 |
| Celltrion USA Inc. | $61.20 | 2 |
| Genentech USA, Inc. | $42.38 | 2 |
| Exelixis Inc. | $41.20 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $39.26 | 2 |
| EISAI INC. | $35.17 | 2 |
| Teva Pharmaceuticals USA, Inc. | $35.13 | 1 |
| Acerta Pharma LLC | $33.50 | 2 |
| Merck Sharp & Dohme Corporation | $32.39 | 2 |
| Stemline Therapeutics Inc. | $30.45 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.01 | 1 |
| ARRAY BIOPHARMA INC | $26.91 | 2 |
| Astellas Pharma US Inc | $22.89 | 1 |
| Rigel Pharmaceuticals, Inc. | $22.55 | 1 |
| PharmaEssentia USA Corporation | $21.52 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $20.25 | 1 |
| Genmab U.S., Inc. | $19.88 | 1 |
| Alexion Pharmaceuticals, Inc. | $18.55 | 1 |
| AVEO Pharmaceuticals, Inc. | $18.02 | 1 |
| Mirati Therapeutics, Inc. | $17.21 | 1 |
By program year
Records — PY2024 (62)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.